The term interstitial lung disease (ILD), also known as Diffuse Parenchymal Lung Disease (DPLD) comprises more than 200 separate disease entities that cause progressive scarring of lung tissue.

The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms of diffuse parenchymal lung disease as part of a multidisciplinary and integrated ...

Studies suggest that IPF accounts for 29-48% of diffuse parenchymal lung disease (DPLD) cases in Indian hospitals. Factors such as air pollution, occupational exposures, biomass fuel inhalation ...

Research conducted in part at National Jewish ... Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases affecting the ...

Screening for preclinical parenchymal lung disease in rheumatoid arthritis ... for the detection of interstitial lung disease in adults with early diffuse cutaneous systemic sclerosis.

Studies suggest that IPF accounts for 29-48 per cent of diffuse parenchymal lung disease (DPLD) cases in Indian hospitals. Factors such as air pollution, occupational exposures, biomass fuel ...

Further, disease categories with the highest expenses were diffuse parenchymal lung disease-diffuse development disorders (45,536) and diffuse parenchymal lung disease-unclear in the non-neonate ...

Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up. Test-retest repeatability for ...

If inflammation in your lungs continues on and does cause scarring, you can develop chronic diffuse interstitial lung disease or pulmonary fibrosis. The scar tissue on your lungs keeps oxygen from ...

Childhood interstitial lung disease, known as “chILD,” is a group ... lung and bone marrow transplant-associated lung diseases, and diffuse alveolar damage of unknown cause.